万古霉素精准给药咨询服务对目标暴露达成率影响的间断时间序列分析
该研究在澳大利亚一家医院开展回顾性审计,评估试点TDM咨询服务通过贝叶斯预测软件和临床专业知识提供AUC引导的万古霉素剂量建议的效果。纳入54个月内1142个静脉万古霉素疗程(≥48小时,成人≥18岁),服务前36个月、服务后18个月。间断时间序列分析显示,服务实施后处于目标范围的中位时间比例从40.1%增加10.4%(95%CI 1.2-19.6%,P=0.03),48-72小时目标达成率提高7.8%(95%CI 1.3-14.3%,P=0.02)。
要点
- TDM咨询服务使万古霉素目标AUC/MIC 400-600的时间比例提高10.4%。
- 服务后48-72小时目标达成率提高7.8%。
- 咨询服务可促进万古霉素治疗目标达成,但仍需优化。
核心结论
- 咨询式TDM服务可促进万古霉素治疗目标达成,但服务优化可能进一步改善万古霉素使用。
研究设计与样本
- 回顾性审计澳大利亚一家医院成人(≥18岁)静脉万古霉素治疗(>48小时)54个月。
- 最终队列1142个疗程(816例患者),服务前835个疗程(596例),服务后307个疗程(220例)。
- 服务提供基于贝叶斯预测软件和临床专业知识的AUC引导剂量建议。
- 采用间断时间序列分析评估每月目标范围时间比例中位数。
主要发现
- 服务前目标范围时间比例中位数为40.1%(95%CI 34.3-46.0%)。
- 服务后目标范围时间比例增加10.4%(95%CI 1.2-19.6%,P=0.03),并在服务后评估期持续。
- 服务后48-72小时目标达成率提高7.8%(95%CI 1.3-14.3%,P=0.02)。
关键数值与推荐
- 万古霉素药代动力学/药效学目标:24小时AUC/MIC 400-600。
临床怎么用
- 临床可借鉴咨询式TDM服务模式,利用贝叶斯预测软件和临床专业知识提供AUC引导剂量建议以改善万古霉素目标达成。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study evaluated the ability of a pilot therapeutic drug monitoring (TDM) Advisory Service to facilitate vancomycin therapeutic target attainment within a real-world clinical setting. The Service provided area under the concentration-time curve (AUC)-guided vancomycin dose recommendations, using Bayesian forecasting software and clinical expertise, to prescribers at an Australian hospital. A retrospective audit of intravenous vancomycin therapy (> 48 hours) in adults (≥ 18 years old) was undertaken over a 54-month period to evaluate attainment of established vancomycin pharmacokinetic/pharmacodynamic targets (AUC over 24 hours / minimum inhibitory concentration: 400-600) before (36-month period) and after (18-month period) Service implementation. Interrupted time series analysis was employed to evaluate monthly measures of the median proportion of therapy spent within the target range. Indices of time to target attainment were also assessed before and after Service implementation. The final cohort comprised 1,142 courses of vancomycin (816 patients); 835 courses (596 patients) and 307 courses (220 patients) administered before and after Service implementation, respectively. Prior to piloting the Service, the median proportion of time in the target range was 40.1% (95% CI, 34.3-46.0%); this increased by 10.4% (95% CI, 1.2-19.6%, P = 0.03) after the Service, and was sustained throughout the post-Service evaluation period. Post-Service target attainment at 48-72 hours after initiation of therapy was increased (7.8%, 95% CI, 1.3-14.3%, P = 0.02). The findings of this study provide evidence that a consultative TDM Service can facilitate attainment of vancomycin therapeutic targets; however, optimization of the Service may further improve the use of vancomycin.
引用
- Stocker SL, Carland JE, Reuter SE, et al. Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series Analysis. Clin Pharmacol Ther. 2020. PMID: 33190285. doi:10.1002/cpt.2113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。